X

Investor News: Certain Directors of DaVita HealthCare Partners Inc (NYSE:DVA) face Investigation

An investigation for investors in NYSE:DVA shares over potential securities laws violations by DaVita HealthCare Partners in connection certain financial statements was announced.

Shares of DaVita HealthCare Partners Inc (NYSE:DVA) declined from $84.09 per share in May 2015 to as low as $61.36 per share on February 12, 2016.

Investors who purchased shares of DaVita HealthCare Partners Inc (NYSE:DVA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DaVita HealthCare Partners Inc (NYSE:DVA) concerning whether a series of statements by DaVita HealthCare Partners regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

In July 2012, DaVita HealthCare Partners Inc announced the settlement of a Qui Tam Whistleblower Lawsuit, in connection with which the Company will pay $55million plus attorneys’ fees, resulting in a second quarter 2012 charge of $78 million. In August 2012 and May 2013 lawsuits were filed against certain directors of DaVita HealthCare Partners Inc, formerly DaVita Inc over alleged breaches of fiduciary duties.

Those who purchased shares of DaVita HealthCare Partners Inc (NYSE:DVA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

John:
Related Post